Dare Bioscience, Inc. Common Stock (DARE)

Health Care·equity
$0.77
+0.16% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
25/ 100
Score level
Below average
5 of 6 checks had data

How it compares with the broader market is one of its lowest-scoring factors, with price trend score is near the bottom of its range.

DARE scores higher than 21% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Dare Bioscience, Inc. Common Stock (DARE) scores 25 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

Insider trades: no reading heldTrendStrengthFinancialsInsidersInsider trades: no reading heldMarketMomentum25/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.26× 30-day average
52-week range
0.69 – 3.78
Market cap
$15.43M
Earnings date
11 Nov 2026
Volume
70,032
Avg. volume (30d)
264,410
Open
0.79
Previous close
0.77
Day's range (regular session)
0.76 – 0.79

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
1.04
P/E (TTM)
—
EPS (TTM)
-0.59

Score breakdown · six named factors

Price trend
5
Strength vs the market
0
Company finances
33
Insider trades
—
Market mood
50
Recent momentum
45

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about DARE right now

Dare Bioscience, Inc. Common Stock (DARE) currently scores 25/100 on the Market Census six-factor composite, at the Below average score level. DARE is +0.16% on the day and -8.23% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of DARE's data reads poorly than well. The level is a "look before you act" flag. It is not advice. DARE's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about DARE itself. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See DARE in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent DARE news

Latest headlines that name Dare Bioscience, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to DARE’s 25, all within 1 point.

Sorted by closeness to DARE’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.